HRAS and hepatocellular carcinoma: In this study, we validated that LL22NC03-N14H11.1 recruited c-Myb to LZTR1 promoter so as to repress LZTR1 transcription and activate H-RAS/MAPK pathway, suggesting LL22NC03-N14H11.1 as a scaffold in HCC as many other lncRNAs do44,51.